Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Tosagestin

From Wikipedia, the free encyclopedia
Chemical compound
Not to be confused withTocogest orTocogestan.
Pharmaceutical compound
Tosagestin
Clinical data
Other namesORG-30659; Exogestin; Letogestin;[1] 11-Methylene-δ15-norethisterone; 17α-Ethynyl-11-methylene-19-nor-δ15-testosterone
Routes of
administration
By mouth
Identifiers
  • (1S,2R,10R,11S,14R,15S)-14-ethynyl-14-hydroxy-15-methyl-17-methylidenetetracyclo[8.7.0.02,7.011,15]heptadeca-6,12-dien-5-one
CAS Number
PubChemCID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC21H24O2
Molar mass308.421 g·mol−1
3D model (JSmol)
  • CC12CC(=C)C3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34
  • InChI=1S/C21H24O2/c1-4-21(23)10-9-18-17-7-5-14-11-15(22)6-8-16(14)19(17)13(2)12-20(18,21)3/h1,9-11,16-19,23H,2,5-8,12H2,3H3/t16-,17-,18-,19+,20-,21-/m0/s1
  • Key:YJSTYQGZKJHXLN-OLGWUGKESA-N

Tosagestin (INNTooltip International Nonproprietary Name,USANTooltip United States Adopted Name) (developmental code nameORG-30659), also known as11-methylene-δ15-norethisterone or17α-ethynyl-11-methylene-19-nor-δ15-testosterone, is aprogestin of the19-nortestosterone group which was under development byOrganon in theUnited States andEurope as ahormonal contraceptive (in combination withethinylestradiol) and for the treatment ofmenopausal symptoms but was never marketed.[2][3][4][5][6]

See also

[edit]

References

[edit]
  1. ^Negwer M, Scharnow HG (2001).Organic-chemical drugs and their synonyms: (an international survey). Wiley-VCH. p. 2104.ISBN 978-3-527-30247-5.
  2. ^World Health Organization (2013),The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances(PDF), p. 95, archived fromthe original(PDF) on August 8, 2016
  3. ^"Tosagestin",AdisInsight, Springer Nature Switzerland AG, retrieved12 July 2016
  4. ^Verhoeven CH, Krebbers SF, Wagenaars GN, Booy CJ, Groothuis GM, Olinga P, Vos RM (November 1998)."In vitro and in vivo metabolism of the progestagen Org 30659 in several species".Drug Metabolism and Disposition.26 (11):1102–1112.PMID 9806953.
  5. ^de Visser SJ, Uchida N, van Vliet-Daskalopoulou E, Fukazawa I, van Doorn MB, van den Heuvel MW, et al. (September 2003). "Pharmacokinetic differences between Caucasian and Japanese subjects after single and multiple doses of a potential combined oral contraceptive (Org 30659 and EE)".Contraception.68 (3):195–202.doi:10.1016/S0010-7824(03)00140-9.PMID 14561540.
  6. ^Obruca A, Korver T, Huber J, Killick SR, Landgren B, Struijs MJ (July 2001)."Ovarian function during and after treatment with the new progestagen Org 30659".Fertility and Sterility.76 (1):108–115.doi:10.1016/S0015-0282(01)01824-6.PMID 11438328.
PRTooltip Progesterone receptor
Agonists
Mixed
(SPRMsTooltip Selective progesterone receptor modulators)
Antagonists
mPRTooltip Membrane progesterone receptor
(PAQRTooltip Progestin and adipoQ receptor)
Agonists
Antagonists
Stub icon

Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it.

Stub icon

This article about asteroid is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Tosagestin&oldid=1205961391"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp